"small cell renormalization" trang 7 - tải miễn phí từ tailieunhanh
Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: A meta-analysis

Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non–small cell lung cancer: A meta-analysis
14    81    0
Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India

Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India
8    57    0
Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer

Raman spectroscopy detects metabolic signatures of radiation response and hypoxic fluctuations in non-small cell lung cancer
13    62    0
LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma

LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma
9    92    0
Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis

Irinotecan-platinum combination therapy for previously untreated extensive-stage small cell lung cancer patients: A meta-analysis
12    76    0
Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study

Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: A case-control observational study
10    48    0
Impact of viral presence in tumor on gene expression in non-small cell lung cancer

Impact of viral presence in tumor on gene expression in non-small cell lung cancer
13    72    0
Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial

Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial
11    81    0
The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients

The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients
9    41    1
Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment

Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment
8    40    1
High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer

High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer
8    49    1
Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer

Differential efficacy of cisplatin plus pemetrexed between L858R and Del-19 in advanced EGFR-mutant non-squamous non-small cell lung cancer
8    69    1
An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy

An inflammation-related nomogram for predicting the survival of patients with non-small cell lung cancer after pulmonary lobectomy
10    41    1
The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: A comprehensive study covering diagnosis, treatment, and outcomes

The effect of low insurance reimbursement on quality of care for non-small cell lung cancer in China: A comprehensive study covering diagnosis, treatment, and outcomes
10    50    1
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    54    1
Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study

Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: A prospective longitudinal observational study
10    86    1
Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis

Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
8    40    1
Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan

Adjuvant chemotherapy versus chemoradiotherapy for small cell lung cancer with lymph node metastasis: A retrospective observational study with use of a national database in Japan
6    67    1
Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer – protocol for a phase II randomised controlled trial

Benefits of home-based multidisciplinary exercise and supportive care in inoperable non-small cell lung cancer – protocol for a phase II randomised controlled trial
12    70    1
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
6    63    1